These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 6141562)

  • 1. Operational models of pharmacological agonism.
    Black JW; Leff P
    Proc R Soc Lond B Biol Sci; 1983 Dec; 220(1219):141-62. PubMed ID: 6141562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.
    Black JW; Leff P; Shankley NP; Wood J
    Br J Pharmacol; 1985 Feb; 84(2):561-71. PubMed ID: 3978322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential errors in agonist dissociation constant estimation caused by desensitization.
    Leff P
    J Theor Biol; 1986 Jul; 121(2):221-32. PubMed ID: 3795994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T
    ACS Chem Biol; 2009 Apr; 4(4):249-60. PubMed ID: 19193052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulus amplification, efficacy, and the operational model. Part II--ternary complex occupancy mechanisms.
    Trzeciakowski JP
    J Theor Biol; 1999 Jun; 198(3):347-74. PubMed ID: 10366491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical treatment of events between the drug-receptor association and the effect.
    Gero A
    J Theor Biol; 1983 Sep; 104(2):249-59. PubMed ID: 6645557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of agonist affinity and efficacy by direct, operational model-fitting.
    Leff P; Prentice DJ; Giles H; Martin GR; Wood J
    J Pharmacol Methods; 1990 May; 23(3):225-37. PubMed ID: 2329803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Have many estimates of efficacy and affinity been misled? Revisiting the operational model of agonism.
    Roche D; van der Graaf PH; Giraldo J
    Drug Discov Today; 2016 Nov; 21(11):1735-1739. PubMed ID: 27349169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic operational models of agonism for G-protein-coupled receptors.
    Hoare SRJ; Pierre N; Moya AG; Larson B
    J Theor Biol; 2018 Jun; 446():168-204. PubMed ID: 29486201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of drug-receptor interactions in vivo: a new approach in pharmacokinetic-pharmacodynamic modelling.
    Van der Graaf PH; Danhof M
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):442-6. PubMed ID: 9352393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The two-modes-of-binding model for partial agonism and the design of partial agonists.
    Topiol S; Osman R; Schulman JM
    Eur J Pharmacol; 1984 Jun; 101(3-4):249-52. PubMed ID: 6468498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial agonism: mechanisms based on ligand-receptor interactions and on stimulus-response coupling.
    Pliska V
    J Recept Signal Transduct Res; 1999; 19(1-4):597-629. PubMed ID: 10071788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Receptor Model With Binding Affinity, Activation Efficacy, and Signal Amplification Parameters for Complex Fractional Response Versus Occupancy Data.
    Buchwald P
    Front Pharmacol; 2019; 10():605. PubMed ID: 31244653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informativeness in stimulus-response modelling.
    Stone M
    J Theor Biol; 1984 Nov; 111(2):261-72. PubMed ID: 6513571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications and limitations of fitting of the operational model to determine relative efficacies of agonists.
    Jakubík J; Randáková A; Rudajev V; Zimčík P; El-Fakahany EE; Doležal V
    Sci Rep; 2019 Mar; 9(1):4637. PubMed ID: 30874590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions.
    Kenakin TP
    Mol Pharmacol; 1992 Apr; 41(4):699-707. PubMed ID: 1569922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy. I: A new method for estimating relative efficacy of full agonists via a newly defined efficacy related parameter.
    Venter DP
    Eur J Pharmacol; 1997 Feb; 320(2-3):223-31. PubMed ID: 9059858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of effector responses by modification of agonist disposition mechanisms.
    Kalsner S
    Can J Physiol Pharmacol; 1976 Jun; 54(3):177-87. PubMed ID: 782671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principles of agonism: undressing efficacy.
    Schwartz TW; IJzerman AP
    Trends Pharmacol Sci; 1998 Nov; 19(11):433-6. PubMed ID: 9850604
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary: The receptor concept in evolution.
    Ariëns EJ; Beld AJ
    Biochem Pharmacol; 1977 May; 26(10):913-8. PubMed ID: 324474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.